Clinical Trial Update: Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of autologous bone marrow–derived cells for the treatment of diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• bone marrow derived autologous cells

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Diabetes Mellitus. | Phase 1, Phase 2 | Status: UNKNOWN